Hims & Hers Health, Inc.

Hims & Hers Health, Inc. Class A's next confirmed earnings release is scheduled for November 9, 2026.

As of June 30, 2026, Hims & Hers Health, Inc. Class A has 233.30M shares outstanding.

As of June 30, 2026, Hims & Hers Health, Inc. Class A maintains a current ratio of 0.93, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Hims & Hers Health, Inc. Class A posted a negative return on equity (ROE) of -32.03, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -5.16, reflecting losses generated across the asset base. The company generates approximately 1.01M in revenue per employee across its workforce of 2,240.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 7.09 indicates how many times Hims & Hers Health, Inc. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Hims & Hers Health, Inc. Class A recorded an income tax benefit of -18.89M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -143.21M and -124.32M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Over the twelve months ended June 30, 2026, Hims & Hers Health, Inc. Class A generated 2.26B in revenue and converted that into -124.32M in net income, yielding earnings per share of -0.52. EBITDA reached -58.93M, while operating income came in at -135.25M.

As of June 30, 2026, Hims & Hers Health, Inc. Class A holds 736.17M in cash and equivalents against 1.35B in total debt, resulting in a net debt position of 661.28M. Total book value stands at 283.66M, with working capital of -86.32M providing operational flexibility.

Hims & Hers Health, Inc. Class A produced 230.60M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -176.65M in capital expenditures, free cash flow totaled 53.95M - equivalent to 0.24 per share.

Over the twelve months ended June 30, 2026, Hims & Hers Health, Inc. Class A posted a gross margin of 68.43, reflecting its pricing power and cost economics. The operating margin of -5.99 and net profit margin of -5.51 provide insight into operational efficiency.